Advisors Capital Management, LLC Biogen Inc. Transaction History

Advisors Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$190.52 - $236.72 $5,525 - $6,864	29 Added 2.63%	1,130 $262,000
Q1 2024 May 06, 2024	SELL	$212.02 - $267.71 $30,954 - $39,085	-146 Reduced 11.71%	1,101 $237,000
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $39,175 - $47,157	176 Added 16.43%	1,247 $323,000
Q3 2023 Nov 15, 2023	BUY	$253.3 - $285.89 $271,284 - $306,188	1,071 New	1,071 $275,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Advisors Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisors Capital Management, LLC with notifications on news.